Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates that entorhinal astrocyte transplantation reduces amyloid pathology and rescues spatial exploration in Alzheimer's mice, suggesting a targeted cell therapy strategy.
Astrocytes in the medial entorhinal cortex (MEC) regulate spatial exploration, yet their functional impairment in Alzheimer's disease (AD) remains poorly understood. Here, we show that fragmented spatial exploration in APP/PS1 mice correlates with diminished exploration‐evoked Ca 2+ transients in MEC layer II astrocytes. To address this, we transplanted glial progenitor cells into the MEC of aged AD mice. The engrafted cells differentiated into homeostatic astrocytes and restored perivascular Aquaporin‐4 polarization. This remodeling significantly reduced amyloid‐beta burden, attenuated neuroinflammation, and preserved synaptic integrity. Crucially, these structural and molecular improvements specifically reversed spatial exploration deficits without affecting general locomotion. Together, our findings suggest that dysfunction in MECII astrocytes is associated with fragmented exploratory behavior. Furthermore, the region‐specific replacement of astrocytes may ameliorate the spatial exploration deficits observed in the AD mouse model.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: